Navigation Links
Sunesis Pharmaceuticals to Present at the Collins Stewart Fourth Annual Growth Conference
Date:7/3/2008

SOUTH SAN FRANCISCO, Calif., July 3 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that Daniel Swisher, Sunesis' Chief Executive Officer and President, will provide a corporate overview at the upcoming Collins Stewart Fourth Annual Growth Conference at 2:30 p.m. Eastern Time on July 8, 2008 in New York, NY.

Interested parties may access a webcast of the presentation by visiting the Sunesis website at http://ir.sunesis.com. A replay of the webcast will be archived on the "Calendar of Events" page in the Investors and Media section of the Sunesis website for two weeks.

About Sunesis Pharmaceuticals

Sunesis is a clinical-stage biopharmaceutical company focused on the development of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, voreloxin (formerly SNS-595), in multiple indications to improve the lives of people with cancer. For additional information on Sunesis Pharmaceuticals, please visit http://www.sunesis.com.

SUNESIS and the logo are trademarks of Sunesis Pharmaceuticals, Inc.


'/>"/>
SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
2. Sunesis Pharmaceuticals Reports New Option Grants Under NASDAQ Marketplace Rule 4350
3. Sunesis Pharmaceuticals SNS-595 Shows Clinical Activity in Patients With Relapsed or Refractory Acute Leukemias; Data Presented in Oral Session at 49th Annual Meeting of the American Society of Hematology
4. Sunesis Pharmaceuticals to Present at Healthcare Investor Conferences in March
5. Sunesis Pharmaceuticals Presents Nonclinical Data on SNS-595 at the Annual Meeting of the American Association for Cancer Research
6. Sunesis Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
7. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
8. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
9. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/15/2020)... ... , ... Sister companies, Special Learning Inc. and ABA Business Growth, are offering ... explores the challenges, risks, and opportunities of private equity investment and acquisition in the ... https://bit.ly/2OU6lxg , Since 2010, more than 60 private equity firms have ...
(Date:2/14/2020)... ... February 14, 2020 , ... Cloudticity announced today it has ... support for healthcare organizations using Amazon Web Services (AWS). , “Our customers want ... to do so,” explained Cloudticity Founder & CEO, Gerry Miller. “In service to ...
(Date:2/13/2020)... ... February 13, 2020 , ... The largest ... Arlington, Dulles-Aldie, Fair Oaks, Fairfax, Fredericksburg, Leesburg, and Woodbridge, as well as two ... fertility specialists have been named as Top Docs for Infertility by Northern Virginia ...
(Date:2/11/2020)... ... February 11, 2020 , ... Soterius, ... today announced its move to a new, significantly larger business premises in Lawrenceville, ... significant expansion in the development of digital technology platforms. , “As our customer ...
(Date:2/10/2020)... ... February 10, 2020 , ... A January 26 article on ... situations. The answer is that – not unlike the skin’s response to dangerous conditions ... serve as an alert to potential damage being done and warn the individual to ...
Breaking Medicine News(10 mins):
(Date:2/14/2020)... (PRWEB) , ... February 14, 2020 , ... ... in Cannabis Science and Commerce beginning fall semester 2020, the first of its ... for individuals interested in a career in the cannabis industry and will provide ...
(Date:2/14/2020)... ATLANTA (PRWEB) , ... February 14, 2020 , ... ... a donation of $55,496 to Children’s Healthcare of Atlanta (Children’s) raised through their ... which a portion of all new or pre-owned vehicle sales between November 29, ...
(Date:2/13/2020)... ... 2020 , ... Achieve TMS Center of Alaska, part of ... is joining our team starting February 18, 2020. , Dr. Gee is a ... and psychodynamic therapy. Her extensive medical experience covers many areas of psychiatry, including ...
Breaking Medicine Technology: